back to Meetings page
- IMMPACT-IX Slide Presentations
- 1. Proof-of-concept trials: industry perspective
- Christine Rauschkolb, MD, PhD
- 2. Proof-of-concept trials: academic perspective
- Ian Gilron, MD
- 3. Single-dose and short-term proof-of-concept trials in neuropathic pain
- Srinivasa Raja, MD
- 4. Single-dose and short-term proof-of-concept trials in non-neuropathic pain
- Nat Katz, MD
- 5. Statistical considerations in small proof-of-concept trials, including crossover designs
- Stephen Senn, PhD
- 6. Futility trials and other adaptive designs
- Cyrus Mehta, PhD
- 7. Dosage determination from preclinical to proof-of-concept trials
- Charles Taylor, PhD
- 8. PK-PD modeling and dosage determination for proof-of-concept trials
- Marc Gastonguay, PhD
- 9. Phenotyping chronic pain patients for proof-of-concept trials
- Ralf Baron, MD